Imatinib intermediates manufacturers
Imatinib intermediates manufacturers
A.R.Life Science has a significant name as the best Imatinib intermediates manufacturers. We
follow strict GMP and ICH standards. We deliver superior quality products and have a dedicated
Research and development team to create the best products at competitive prices. We develop
both customized and standard packages depending on our customer requirements. To maintain
great quality as Imatinib intermediates manufacturers we have committed staff and we follow
stringent guidelines.
We established in 2007, are an ISO 9001:2015 certified organization. Imatinib is developed as a
small molecule used in the treatment of certain types of cancer. It is utilized in chronic
myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and also in treating a
number of other cancerous cells. It is the first in the class of inhibiting agents that act
particularly on tyrosine kinase enzymes. All our products are available in powdered form, with
100gms as the minimum quantity of order.
Imatinib intermediate is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow. They act as chemical messengers. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing.
152460-10-1:
- Product Features
- Advantages
- Applications
- Specifications
- Form: Powder
- Minimum order quantity: 100gram
- Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
- Usage/Application: Commercial
- Manufacturer: A. R. Life sciences Pvt Ltd.
Imatinib Intermediates Specifications:
Intermediate | CAS No | API/End Use | Status | Purity |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 | Imatinib | Commercial | 99.5% |
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | 106261-49-8 | Imatinib | Commercial | 99.45% |
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | 152460-09-8 | Imatinib | Commercial |